For_PIN
the_DT
purposes_NN
of_PIN
impairment_NOMZ
testing_GER
of_PIN
goodwill_NN
,_,
goodwill_NN
values_NN
have_VPRT [PEAS]
been_VBN [PASS]
compared_VBN
against_PIN
discounted_VBN
forecast_NN
cash_NN
flows_NN
of_PIN
the_DT
relevant_JJ
cash-generating_JJ
unit_NN
on_PIN
a_DT
value_NN
in_PIN
use_NN
basis_NN
._.
The_DT
forecasts_NN
include_VPRT
post_NN
tax_NN
profit_NN
increases_NN
and_CC
the_DT
corresponding_JJ
cash_NN
flows_NN
._.
A_DT
discount_NN
rate_NN
of_PIN
10_CD
%_NN
has_VPRT [PEAS]
been_VBN [PASS]
applied_VBN
to_PIN
the_DT
calculations_NOMZ
._.
The_DT
carrying_VBG
amounts_NN
of_PIN
goodwill_NN
allocated_VBN [WZPAST]
to_PIN
cash-generating_JJ
units_NN
are_VPRT
as_IN
follows_VPRT
:_:
2005 2004 000 000_CD
M_NN
&_CC
M_NN
product_NN
unit_NN
2,511_CD
2,463_CD
Alitea_NN
product_NN
unit_NN
2,153_CD
2,162_CD
1,869_CD
-_:
Spirax_NN
Sarco_NN
,_,
Inc._NN
._.
USA_NN
UK_NN
Supply_NN
product_NN
unit_NN
1,625_CD
1,683_CD
1,377_CD
1,384_CD
Watson-Marlow_NN
Bredel_NN
,_,
South_NN
Africa_NN
Mitech_NN
product_NN
unit_NN
1,175_CD
-_:
Spirax-Sarco_NN
S._NN
A._NN
S._NN
France_NN
1,096_CD
1,135_CD
Other_JJ
cash-generating_JJ
units_NN
3,227_CD
3,035_CD
15,033_CD
11,862_CD
14_CD
LOANS_NN
TO_PIN
SUBSIDIARIES_NN
PARENT_NN
COMPANY_NN
2005 2004 000 000_CD
Cost_NN
:_:
At_PIN
1st_CD
January_NN
12,207_CD
11,380_CD
Exchange_NN
adjustments_NOMZ
14_CD
166_CD
12,193_CD
11,546_CD
Loans_NN
2,678_CD
745_CD
Repayments_NOMZ
-_:
84_CD
At_PIN
31st_CD
December_NN
14,871_CD
12,207_CD
Amounts_NN
written_VBN [PUBV] [WZPAST]
off_PIN
:_:
At_PIN
1st_CD
January_NN
and_CC
31st_CD
December_NN
1,042_CD
1,042_CD
Net_JJ
book_NN
value_NN
:_:
At_PIN
31st_CD
December_NN
13,829_CD
11,165_CD
Spirax-Sarco_NN
Engineering_GER
plc_NN
51_CD
